Physician profile
Lawrence K Monahan
NPI 1457342834
$1,466.24
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $693.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $402.17 | 2019-2020 | |
| Glaxosmithkline, LLC. | $257.53 | 2019-2020 | |
| Amarin Pharma, INC. | $254.64 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $149.63 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $49.34 | 2020 | |
| Novo Nordisk INC | $43.98 | 2019 | |
| Pfizer INC. | $41.95 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.05 | 2019 | |
| Allergan, INC. | $25.68 | 2020 | |
| Eisai INC. | $21.11 | 2020 | |
| Novartis Pharmaceuticals Corporation | $20.63 | 2020 | |
| Dexcom, INC. | $19.26 | 2019 | |
| Amgen INC. | $18.22 | 2019 | |
| Medtronic Vascular, INC. | $17.52 | 2020 | |
| Biocryst Pharmaceuticals, INC. | $15.98 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $14.12 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.84 | 2019 | |
| Sanofi Pasteur INC. | $11.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Monahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.